# Elad Levy **Entity class:** Concept or analytic term **Type:** Person **Collection:** [[collections/Neurotech|Neurotech]] **Primary source:** [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] ## Definition Elad Levy is identified as a co-principal investigator of Synchron's COMMAND study. ## Relationships [[wiki/Elad Levy|Elad Levy]] is related to [[wiki/COMMAND Study|COMMAND]] and [[wiki/Synchron|Synchron]] through clinical investigation. <!-- BEGIN HUMANIZED RELATIONSHIPS 2026-09-11 --> This entry's documented connections are expressed in its definition and related-work routes, with provenance retained in the source-linked material. <!-- END HUMANIZED RELATIONSHIPS 2026-09-11 --> ## Source route [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[collections/Neurotech|Neurotech]] ## Related Work in the Corpus <!-- BEGIN HUMANIZED CORPUS ROUTES 2026-09-11 --> - In [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]], **Synchron: The Minimally Invasive Counter-Geometry** provides the narrative context for **Elad Levy**: The COMMAND early feasibility study (NCT05035823), the first FDA-approved trial of a permanently implanted BCI, completed in November 2025 with results presented by co-principal investigator Dr. <!-- END HUMANIZED CORPUS ROUTES 2026-09-11 -->